KRYSTAL BIOTECH INC (KRYS) Stock Analyst Earnings Estimates
NASDAQ:KRYS - Nasdaq - US5011471027 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50.699M | 290.515M 473.02% | 407.02M 40.10% | 609.42M 49.73% | 882.75M 44.85% | 1.038B 17.59% | 1.282B 23.51% | 1.49B 16.22% | 1.915B 28.52% | 1.248B -34.83% | ||
| EBITDA YoY % growth | -116.14M -77.29% | -92.22M 20.60% | 109.909M 219.18% | 153.61M 39.76% | 253.32M 64.91% | 322.04M 27.13% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -120.2M -76.04% | -97.227M 19.11% | 103.195M 206.14% | 153.12M 48.38% | 293.36M 91.59% | 478.09M 62.97% | 637.81M 33.41% | 877.46M 37.57% | 1.055B 20.23% | 1.402B 32.89% | 911.37M -35.00% | |
| Operating Margin | N/A | -191.77% | 35.52% | 37.62% | 48.14% | 54.16% | 61.45% | 68.44% | 70.81% | 73.21% | 73.03% | |
| EPS YoY % growth | -4.51 -47.39% | -3.40 24.61% | 2.99 187.94% | 5.75 92.44% | 9.36 62.72% | 13.71 46.45% | 20.74 51.23% | 28.37 36.79% | 34.10 20.22% | 75.68 121.93% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.13 24.67% | 1.34 -12.02% | 1.79 48.75% | 2.49 92.93% | 2.69 137.36% | 3.07 129.58% | 3.47 94.29% | 3.99 60.25% | 3.91 45.08% | 4.29 39.87% |
| Revenue Q2Q % growth | 95.203M 13.55% | 107.35M 17.79% | 126.03M 42.92% | 166.3M 73.15% | 179.58M 88.63% | 199.93M 86.24% | 192.09M 52.42% | 215.22M 29.42% | 214.04M 19.19% | 231.91M 16.00% |
| EBITDA Q2Q % growth | 33.075M -17.50% | 33.181M -31.01% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 28.332M -18.90% | 30.584M -26.09% | 62.496M 72.75% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.29 143.40% | 1.15 | 0.14 | 12.14% |
| Q1 2025 Q2Q % growth | 1.20 3,900.00% | 1.39 | -0.19 | -13.89% |
| Q4 2024 Q2Q % growth | 1.52 406.67% | 1.19 | 0.33 | 27.68% |
| Q3 2024 Q2Q % growth | 0.91 231.88% | 0.92 | -0.01 | -0.73% |
| Q2 2024 Q2Q % growth | 0.53 142.40% | 0.59 | -0.06 | -10.41% |
| Q1 2024 Q2Q % growth | 0.03 101.70% | 0.15 | -0.12 | -80.01% |
| Q4 2023 Q2Q % growth | 0.30 124.00% | -0.43 | 0.73 | 169.20% |
| Q3 2023 Q2Q % growth | -0.69 41.03% | -0.29 | -0.40 | -136.53% |
| Q2 2023 Q2Q % growth | -1.25 -13.64% | -0.75 | -0.50 | -66.36% |
| Q1 2023 Q2Q % growth | -1.76 -77.78% | -1.47 | -0.29 | -19.94% |
| Q4 2022 Q2Q % growth | -1.25 -31.58% | -1.35 | 0.10 | 7.28% |
| Q3 2022 Q2Q % growth | -1.17 -67.14% | -1.24 | 0.07 | 5.76% |
| Q2 2022 Q2Q % growth | -1.10 -48.65% | -1.04 | -0.06 | -6.18% |
| Q1 2022 Q2Q % growth | -0.99 -47.76% | -1.07 | 0.08 | 7.44% |
| Q4 2021 Q2Q % growth | -0.95 -79.25% | -0.75 | -0.20 | -27.15% |
| Q3 2021 Q2Q % growth | -0.70 -42.86% | -0.75 | 0.05 | 7.08% |
| Q2 2021 Q2Q % growth | -0.74 -100.00% | -0.77 | 0.03 | 4.23% |
| Q1 2021 Q2Q % growth | -0.67 -116.13% | -0.57 | -0.10 | -17.93% |
| Q4 2020 Q2Q % growth | -0.53 -70.97% | -0.61 | 0.08 | 12.43% |
| Q3 2020 Q2Q % growth | -0.49 -96.00% | -0.48 | -0.01 | -2.45% |
| Q2 2020 Q2Q % growth | -0.37 | -0.48 | 0.11 | 22.82% |
| Q1 2020 Q2Q % growth | -0.31 -6.90% | -0.45 | 0.14 | 31.59% |
| Q4 2019 Q2Q % growth | -0.31 | -0.34 | 0.03 | 7.50% |
| Q3 2019 Q2Q % growth | -0.25 | -0.40 | 0.15 | 36.92% |
| Q2 2019 Q2Q % growth | -0.37 | -0.33 | -0.04 | -11.86% |
| Q1 2019 Q2Q % growth | -0.29 | -0.34 | 0.05 | 13.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 96.042M 36.65% | 93.77M | 2.272M | 2.42% |
| Q1 2025 Q2Q % growth | 88.183M 94.88% | 98.167M | -9.984M | -10.17% |
| Q4 2024 Q2Q % growth | 91.139M 116.26% | 92.299M | -1.16M | -1.26% |
| Q3 2024 Q2Q % growth | 83.841M 879.91% | 84.604M | -763K | -0.90% |
| Q2 2024 Q2Q % growth | 70.284M | 66.642M | 3.642M | 5.47% |
| Q1 2024 Q2Q % growth | 45.25M | 48.368M | -3.118M | -6.45% |
| Q4 2023 Q2Q % growth | 42.143M | 29.179M | 12.964M | 44.43% |
| Q3 2023 Q2Q % growth | 8.556M | 6.447M | 2.109M | 32.71% |
| Q1 2023 Q2Q % growth | 204K | -204K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.18% | -28.82% | 0% | -19.52% |
| Revenue | -1.15% | -15.78% | -0.95% | -6.68% |